Clinical Trials Directory

Trials / Unknown

UnknownNCT04596748

Oral Probiotics on the Microbiome and Lipidome in Acne Vulgaris

Prospective Randomized Double-Blind Placebo-Controlled Study of Oral Probiotics on the Microbiome and Lipidome in Acne Vulgaris

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
70 (estimated)
Sponsor
Integrative Skin Science and Research · Industry
Sex
All
Age
13 Years – 45 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine how probiotics affect sebum production and gut health in those with acne vulgaris.

Detailed description

Probiotics have been shown in previous pilot studies to be helpful in acne and this study aims to examine how the gut microbiome and skin biophysical properties are shifted in those with acne vulgaris. In particular, this study will assess the influence of oral spore based probiotics on the skin sebum production and will assess how probiotics influence the gut microbiome and the blood levels of short chain fatty acids.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTProbioticBacillus Subtilis, Bacillus Clausii, Bacillus Coagulans, Bacillus Indicus HU36, MCC 102
DIETARY_SUPPLEMENTPlaceboPlacebo caps

Timeline

Start date
2020-05-11
Primary completion
2021-03-01
Completion
2021-03-01
First posted
2020-10-22
Last updated
2020-11-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04596748. Inclusion in this directory is not an endorsement.

Oral Probiotics on the Microbiome and Lipidome in Acne Vulgaris (NCT04596748) · Clinical Trials Directory